XML 42 R31.htm IDEA: XBRL DOCUMENT v3.25.1
Financial Instruments and Fair Value Measurements (Tables)
6 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Cash and Cash Equivalents
The following reconciles cash and equivalents and restricted cash reported within the Company's condensed consolidated balance sheets at March 31, 2025 and September 30, 2024 to the total of these amounts shown on the Company's condensed consolidated statements of cash flows:
(Millions of dollars)March 31, 2025September 30, 2024
Cash and equivalents$667 $1,717 
Restricted cash80 139 
Cash and equivalents and restricted cash$747 $1,856 
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The fair values of the Company’s financial instruments are as follows:
(Millions of dollars)Basis of fair value measurementMarch 31, 2025September 30, 2024
Institutional money market accounts (a)Level 1$— $285 
Current portion of long-term debt (b)Level 2858 1,748 
Long-term debt (b)Level 216,538 17,199 
(a)These financial instruments are recorded within Cash and equivalents on the condensed consolidated balance sheets. The institutional money market accounts permit daily redemption. The fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions.
(b)Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.
Transfer of Financial Assets Accounted for as Sales The amounts transferred and yet to be remitted under factoring arrangements are provided below.
Three Months Ended March 31,Six Months Ended March 31,
(Millions of dollars)2025202420252024
Trade receivables transferred to third parties under factoring arrangements$369 $361 $728 $740 
March 31, 2025September 30, 2024
Amounts yet to be collected and remitted to the third parties$345 $254